Oxidative stress has an important role in the pathogenesis of many muscle diseases. The major contributors to oxidative stress in muscle tissue are reactive oxygen species such as oxygen ions, free radicals, and peroxides. Insulin-like growth factor I (IGF-I) has been shown to increase muscle mass and promote muscle cell proliferation, differentiation, and survival. We, therefore, hypothesized that IGF-I might also be cytoprotective for muscle cells during oxidative stress. Exogenous hydrogen peroxide (H 2 O 2 ) was used to induce oxidative stress/damage in two types of skeletal muscle cells. Apoptotic pathways were assessed after the oxidative damage and the effects of IGF-I on oxidative stress in muscle cells were examined. Different IGF-I sub-pathways were analyzed with measurement of the expression of pro-and antiapoptotic proteins. It was found that H 2 O 2 diminishes muscle cell viability and induces a caspase-independent apoptotic cell death. Pretreatment with IGF-I protects muscle cells from H 2 O 2 -induced cell death and enhances muscle cells survival. This effect appears to result from the promotion of the anti-apoptotic protein, Bcl2. Further investigation shows that protection is via an IGF-I sub-pathway: PI3K/Akt and ERK1/2 MAPK pathways. Protecting muscle cells from oxidative damage presents a potential application in the treatment of the muscle wasting, which appears in many muscle pathologies including Duchenne muscle dystrophy and sarcopenia.
Many pathological muscle conditions, such as Duchenne muscle dystrophy (DMD) and sarcopenia, have been found to be associated with an increase in oxidative stress. 1 DMD is a severe progressive X-linked muscle disease with the absence of dystrophin, a protein providing structural integrity on the muscle cell membrane. Owing to the fragility of the DMD muscle membrane, normal muscular contraction in DMD destabilizes the myocyte membrane, causing intracellular accumulation of calcium. This stimulates oxidative metabolism, which generates free radicals and triggers the key pathological processes. 2 Sarcopenia is a condition with degenerative loss of skeletal muscle mass and strength associated with ageing. Mitochondrial (Mt) production of reactive oxygen species (ROS) has been shown to increase in skeletal muscle over the course of ageing, 3 which in turn reduces bioenergetic efficiency and leads to muscle fiber atrophy/loss. 4 Although DMD and sarcopenia have different pathological properties, they share a common syndrome, that is, muscle wasting. Abundant evidence implicates oxidative stress as a potential regulator of proteolytic pathways leading to muscle wasting. 5 Oxidative stress results from the activities of the reactive compounds called ROS. ROS are natural by-products in the normal metabolism of oxygen and have important roles in cell signalling. ROS including oxygen ions, free radicals, and peroxides usually have highly reactive properties because of the presence of unpaired valence shell electrons. During physiological homeostasis overall oxidative balance is maintained by the removal of ROS via a variety of antioxidants to match the production of ROS from a variety of sources. 6 Overproduction of ROS or lack of antioxidants leads to oxidative stress and cause oxidative damage such as deleterious cellular effects, cell death, and diverse pathological conditions. One major contributor to oxidative damage is hydrogen peroxide (H 2 O 2 ), which is produced from superoxide that leaks from the mitochondria. Exogenous H 2 O 2 has been used to induce myotube oxidative stress 7 and atrophy 8 in previous studies. Preventing oxidative stress or protection against oxidative damage offers a potential strategy for cure or delaying muscle wasting. 1, 4 Insulin-like growth factor I (IGF-I) has been found to contribute to oxidative balance and has a protective effect against iron-induced-lipid oxidative stress. 9 We, therefore, hypothesized that IGF-I might be able to protect muscle cells from oxidative stress. To test this hypothesis exogenous H 2 O 2 was used to induce skeletal muscle cell oxidative stress/damage. The effects of IGF-I on oxidative stress in muscle cells was examined and different IGF-I pathways were analyzed. It was found that IGF-I has a protective effect on muscle cells after oxidative stress. Protecting muscle cells from oxidative damage by IGF-I offers a potential application in a variety of muscle pathologies.
MATERIALS AND METHODS Reagents
Recombinant human IGF-I was purchased from Peprotech EC (UK). Caspase 3/7, 8, and 9 activity assay kits and CellTiter-Blue cell viability assay kits were purchased from Promega (Madison, USA). Yo Pro-1 iodide was purchased from Invitrogen (Paisley, UK). Polyclonal anti-Akt and PhosphoAkt (Ser473) antibodies were purchased from New England Bio-labs (Hitchin, UK). Polyclonal anti-human Bax and Bcl2 antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, USA). Anti-rabbit IgG antibody was purchased from GE Healthcare (Amersham, UK). LY294002, SB 203580, and MEK1/2 inhibitor were purchased from Merck (UK). TUNEL assay kit was purchased from Calbiochem (UK). Apoptotic DNA ladder detection kit was purchased from Millipore (USA). All cell culture media, serums, and antibiotics were purchased from GIBCO (UK).
Cell Lines and Culture Conditions C 2 C 12 (mouse) and L 6 E 9 (rat) skeletal muscle cell lines were purchased from European Collection of Cell Cultures (ECACC). Cells were cultured and maintained at 37 1C in 5% CO 2 /95% air using DMEM medium containing 10% fetal bovine serum (FBS) and 1% penicillin and streptomycin (PenStrep). All cells were used at passages 10-30 after their receipt from the supplier.
Cell Treatments
Pretreatment with IGF-I C 2 C 12 or L 6 E 9 cells were seeded in 96-well plates at a density of 2 Â 10 4 cells/well in DMEM medium containing 10% FBS, 1% PenStrep, and maintained for 24 h. After seeding, cells were pretreated with different concentrations (0, 50, and 100 ng/ml) of IGF-I (Peprotech EC, UK) in DMEM medium containing 10% FBS and 1% PenStrep at 37 1C in 5% CO 2 / 95% air for 24 h. After pretreatments, cells were challenged with different concentrations of H 2 O 2 .
H 2 O 2 induce cell oxidative stress After seeding or pretreatment with IGF-I, cells were challenged by the addition of H 2 O 2 solution at the desired final concentrations (0.25, 0.5 and 1 mM) in DMEM medium containing 10% FBS and 1% PenStrep at 37 1C in 5% CO 2 / 95% air for 2 h. After treatments and oxidative challenge, cells were subjected to cell viability or cell death assays.
Inhibition of PI3K/Akt, p38, and ERK1/2 MAPK pathways To determine which pathway IGF-I executes its cell protection from oxidative injury, a cell permeable phosphatidylinositol 3 kinase (PI3K) inhibitor (LY294002), p38 mitogenactivation protein kinase (MAPK) inhibitor (SB 203580), or MEK1/2 inhibitor (cat no. 444939, Merck) were used to inhibit PI3K/Akt, p38MAPK, or MEK1/2 MAPK pathways. Briefly, C 2 C 12 and L 6 E 9 cells were seeded in 96-well plates at a density of 1 Â 10 4 cells/well in DMEM medium containing 10% FBS and 1% PenStrep and maintained for 24 h. After seeding, cells were treated with IGF-I at a concentration of 100 ng/ml plus LY294002 (20 mM), SB203580 (20 mM), or MEK1/2 inhibitor (20 mM) in DMEM medium containing 10% FBS and 1% PenStrep at 37 1C in 5% CO 2 /95% air for 24 h before they were challenged with different concentrations of H 2 O 2 . After treatments and oxidative challenge, cells were subjected to cell viability or cell death assays.
Cell Viability Assay
After 24 h of pretreatment with different concentration of IGF-I and 2 h of oxidative challenge, cell viability was assessed using a previously reported method. 10, 11 Briefly, after treatment with IGF-I and oxidative stress, 20 ml of CellTiterBlue reagent (Promega) was added to each well without the removal of the medium. The plate was rocked on an orbital shaker gently for 2 min to help mixing of the CellTiter-Blue reagent with culture medium. Cells were then further incubated at 37 1C in 5% CO 2 /95% air for 5 h. Fluorescence was measured with excitation at 530 and emission at 620 nm using a fluorescent plate reader (Fluoroskan Ascent FL; Labsystems, Helsinki, Finland). The experiments were performed in triplicate and repeated on two separately initiated cultures.
Cell Death Assay
After pretreatment by IGF-I and oxidative stress by H 2 O 2 , dead cells were assessed using a previously reported method. 11, 12 Detection of DNA Fragmentation DNA fragmentation, the hallmark of apoptosis, was examined using DNA ladder detection kit (Millipore). Briefly, C 2 C 12 and L 6 E 9 cells were seeded in a 5-ml flask at a density of 2 Â 10 6 cells/flask with DMEM media containing 10% FBS and 1% PenStrep. After overnight incubation, cells were treated with H 2 O 2 (C 2 C 12 and L 6 E 9 cells at concentrations of 1 and 0.25 mM, respectively) for 2 h. After the treatment, cells were washed three times with PBS and pelletted by centrifugation. The DNA fragments were isolated and purified according to the manufactory instruction and visualized by electrophoresis.
Caspase Activity Assay
After oxidative stress, cells were subjected to caspase 3/7, 8, and 9 activity measurements with Caspase-Glo assay kit (Promega). Briefly, the plates containing cells were removed from the incubator and allowed to equilibrate to room temperature for 30 min. A volume of 100 ml of Caspase-Glo reagent was added to each well, the contents of wells were gently mixed with a plate shaker at 300-500 r.p.m. for 30 s. The plate was then incubated at room temperature for 2 h. The luminescence of each sample was measured in a platereading luminometer (Thermo Labsystems) with parameters of 1-min lag time and 0.5 s/well read time. The experiments were performed in triplicate and repeated on two separately initiated cultures. To assess whether the Caspase-Glo assay kit is suitable for measurement of caspase activity in muscle cells, both muscle cell lines were treated by cycloheximide at 0.1 mM for 24 h (cycloheximide is a protein translation inhibitor, which has been proven to cause both muscle cell apoptosis), caspase 3/7, 8, and 9 activity was measured with Caspase-Glo assay kit using the above protocol.
Protein Extraction and Western Blotting C 2 C 12 and L 6 E 9 cells were seeded in a six-well plate at a density of 18 Â 10 5 cells/well with DMEM medium containing 10% FBS and 1% PenStrep and incubated at 37 1C in 5% CO 2 /95% air for 24 h. After seeding, cells were washed with serum-free medium (99% DMEM, 1% PenStrep) three times and then cultured in serum-free medium for 24 h. The volume of medium in each well was 3 ml. After serum deprivation, the cells were divided into four groups with each group containing two wells. For the first group, cells were incubated with serum-free medium, the second group were incubated with serum-free medium containing IGF-I (100 ng/ml), the third group were incubated with serum-free medium containing IGF-I (100 ng/ml) and LY294002 (20 mM), and the fourth group were incubated with serumfree medium containing IGF-I (100 ng/ml) and SB203580 (20 mM). All treatments lasted 24 h. After treatment, cells were washed three times with PBS, lysed by the addition of RIPA buffer containing protease inhibitor cocktail (Roche), and harvested with a cell scraper. To assist cell lysis, cell suspensions were repeatedly frozen and thawed. Total protein concentration in the samples was determined using a modified Lowry protein assay kit (Pierce Biotechnology, USA). In total, 60 mg of total protein was mixed with the same volume of the laemmli sample buffer containing 4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% bromphenol blue and 0.125 M tris HCl, pH approximately 6.8 (Sigma, UK). The samples were then denatured by heating at 95 1C for 5 min. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was used to separate the proteins, which were then electro-blotted on to polyvinylidene fluoride (PVDF) membrane (Bio-Rad, USA). The membrane was blocked with 5% milk in PBS (Marvel semi-skimmed milk powder) and incubated with primary antibodies at 4 1C overnight followed by incubation with anti-rabbit IgG antibody conjugated with horse radish peroxidase (Dako, UK) at 1/2000 dilution. The primary antibody dilution for Bax, Bcl2 and Akt was 1/200, for Phospho-Akt was 1/1000. After secondary antibody incubation, the membrane was washed three times with PBS and incubated with Super Signal West Dura extended duration Substrate (Pierce, USA) for 5 min and the protein bands were illuminated with a chemi-doc system (Bio-Rad). The density of protein bands was measured using densitometry software (Molecular Analyst, windows software for Bio-Rad image analysis system version 1.5, USA).
Statistical Analysis
All data have been examined and shown a normal distribution. All results were expressed as mean ± s.e.m. One-way ANOVA (Prism version 4 2004 edition, USA) with multiple comparison tests were used. Statistical analysis was performed on n ¼ 6 samples and Bonferroni's Multiple Comparison Test was used after ANOVA. Po0.05 was considered as significant and indicated as *Po0.01 was considered as higher significance and indicated as **P40.05 was considered as not significant and marked as NS.
RESULTS H 2 O 2 -Induced Muscle Cell Oxidative Stress
Two mammalian skeletal muscle cell lines (C2C12 and L6E9) were used in the experiment. After 2 h of exposure to different concentrations of H 2 O 2 , survival of both C 2 C 12 and L 6 E 9 cells decreased in a dose-dependent manner ( Figures 1a  and b) ; the higher the concentration of H 2 O 2 , the less the survival of cells. When the ratios of dead cells to survival cells was examined, it revealed that exposure to H 2 O 2 also increased the number of dead cells in a dose-dependent manner (Figures 1c and d) . This indicates exogenous H 2 O 2 -induced muscle cell oxidative stress, which not only reduced cell viability, but also caused cell death. It is interesting to note that L 6 E 9 cells are more susceptible to H 2 O 2 than C 2 C 12 cells as it is observed that all three concentrations (0.25, 0.5, and 1 mM) of H 2 O 2 decrease L 6 E 9 cell viability significantly compared with the untreated control cells (Figure 1b) , while only the highest concentration (1 mM) of H 2 O 2 reduces the C 2 C 12 cell viability significantly (Figure 1a ). Similar to cell survival, the ratio of dead cells is also significantly higher in L 6 E 9 ( Figure 1d ) cells than C 2 C 12 cells (Figure 1c) .
To analyze whether H 2 O 2 -induced cell death is a type of apoptosis, TUNEL assay was used to examine dead cells after H 2 O 2 exposure. The results showed that H 2 O 2 -induced apoptosis in both C 2 C 12 and L 6 E 9 cells after 1-and 2-h exposure (Figure 1e ). It seems that 2-h exposure caused more apoptosis than 1-h exposure. To validate the method, camptothecin that has been proven to be able to induce muscle cell apoptosis previously, 13 was included in the experiment as a positive control. It was found that exposure to camptothecin for 2 h also caused apoptosis in both cell lines.
To further prove H 2 O 2 -induced cell death is a type of apoptosis, DNA fragmentation was examined. The results showed that H 2 O 2 -induced DNA fragmentation in both cell lines after 2-h exposure (Figure 1f) Figures  1b and d-f) , however, it does not affect caspase 3/7, 8, and 9 activity (Figures 2a and b) in either cell lines. It was also shown that cycloheximide treatments (which has been proven to be able to cause both cell lines apoptotic death) can significantly increase the activity of caspase 3/7 and 9 in both cell lines and caspase 8 in C 2 C 12 but not in L 6 E 9 cells (Figures  2c and d) measured by Caspase-Glo assay kit indicating the kit used in experiments is suitable for the measurement of caspase activity in both muscle cell lines. All together these data suggest that H 2 O 2 -induced muscle cell death is a type of caspase-independent apoptosis.
IGF-I Increase Muscle Cell Survival After H 2 O 2 -Induced Oxidative Stress
To determine whether IGF-I has a protective effect on muscle cells from H 2 O 2 -induced oxidative injury, muscle cells were pretreated with different concentrations of IGF-I for 24 h before they were exposed to a variety concentrations of H 2 O 2. It was found that the viability of both muscle cell lines was higher in the IGF-I pretreated groups than the untreated control group (Figures 3a and b) . The increase in the viability of the pretreated cells was in a dose-dependent manner in both cell lines indicating that IGF-I can increase muscle cell survival after oxidative stress. It is interesting to note that the response to oxidative challenge and IGF-I treatment were different in the two cell lines. The greater viable cell loss in L 6 E 9 cells (Figure 3b ) compared with C 2 C 12 cells (Figure 3a) , after H 2 O 2 treatment, indicates that L 6 E 9 cells are more sensitive to oxidative challenge than the C 2 C 12 cells. Although IGF-I has a protective effect in both cell lines in a dosedependent manner, the extent of protection is different. In C 2 C 12 cells, the highest concentration of IGF-I (100 ng/ml) always brings the cell survival level to the level of the untreated normal cells no matter what concentration of H 2 O 2 is used in oxidative stress (Figure 3a) . In the L 6 E 9 cells, the highest concentration of IGF-I (100 ng/ml) only brings the cell survival level to the level of the untreated normal cells in the lowest level of H 2 O 2 treatment (0.25 mM), while in the higher levels of H 2 O 2 treatments (0.5 and 1 mM), the highest concentration of IGF-I only brings cell survival to the level of 65 and 45% of the untreated normal cells, respectively (Figure 3b) . The difference may be due to the fact that L 6 E 9 cells are more vulnerable to the higher level of H 2 O 2 treatments (0.5 and 1 mM), which decrease cell viability to the 45 and 25% of the untreated normal cells, respectively ( Figure  3b ) and IGF-I protection may not be influential enough to recover these severely damaged cells.
IGF-I Reduced Muscle Cell Death After H 2 O 2 -Induced Oxidative Stress
After pretreatment with IGF-I and challenge by H 2 O 2 , cell death was assessed by a previously reported method. 11, 12 The results show that a higher concentration of H 2 O 2 increases 2 C 12 (a, c) and L 6 E 9 (b, d) skeletal muscle cells were challenged by H 2 O 2 at concentrations of 0.25, 0.5, and 1 mM for 2 h. Cell viability was determined with CellTiter-Blue reagent (Promega), cell survival (%) (a, b) was expressed as percentage of viable cell in treated groups to the untreated control group (0 mM). Dead cell was assessed with YOPRO-iodide (Invitrogen); cell death/survival ratio (c, d) was calculated according to the method mentioned in the text. All data were represented as mean ± s.e.m. of six samples (n ¼ 6). Po0.05 was considered as significant and indicated as *Po0.01 as higher significance and indicated as **P40.05 as not significant and marked as NS. C 2 C 12 and L 6 E 9 cells were seeded in chambers mounted on glass slide for 24 h and treated by H 2 O 2 (C 2 C 12 and L 6 E 9 cells at concentrations of 1 and 0.25 mM, respectively) for 1 and 2 h. One group of cells was treated by camptothecin (20 mM) for 2 h as a positive control; one group was untreated as negative control. After treatment, apoptotic cells were detected by TUNEL assay. Dark blue stained cells are apoptotic cells (e). C 2 C 12 and L 6 E 9 cells were seeded in a 5-ml flask at a density of 2 Â 10 6 cells/flask overnight and then treated with H 2 O 2 (C 2 C 12 and L 6 E 9 cells at concentrations of 1 and 0.25 mM, respectively) for 2 h. Each cell line included one group that was untreated as negative control (N). The DNA fragments were detected by apoptotic DNA ladder detection kit (Millipore), and DNA fragmentation occurs in both cell line (f). It seems that H 2 O 2 caused more severe DNA destruction in C 2 C 12 cells than in L 6 E 9 cells.
cells death in both cell lines (Figures 4a and b) . In respect of cell death, the response of two cell lines to oxidative stress is different. In C 2 C 12 cells, only the highest concentration (1 mM) of H 2 O 2 causes significant cell death compared with the untreated cells (Figure 4a ), while in L 6 E 9 cells both concentrations of H 2 O 2 (0.5 and 1 mM) cause significantly more cell death compared with untreated cells (Figure 4b ). This may also be due to the fact that L 6 E 9 cells are more vulnerable to H 2 O 2 -induced oxidative stress. When cells were pretreated by IGF-I, the trends of cell death appear to be neutralized in both cell lines (Figures 4a and b) indicating IGF-I can prevent cells from death induced by oxidative stress. (Figures 6a-d) .
The MAPK pathway is another major signal transduction cascade, which ultimately triggers multiple biological cell responses of IGF-I. 14 To evaluate the role of the MAPK pathways in IGF-I protection cells from oxidative stress, two inhibitors of the MAPK pathway were used. One is SB203580, which specifically inhibits p38 MAPK and has been used to identify the physiological roles and targets of p38MAPK; 15 another one is the MEK1/2 inhibitor, which selectively inhibits MEK1 and MEK2. Interestingly, the MEK1/2 inhibitor not only markedly neutralized IGF-I protection in both cell lines (Figures 5e-h ), but also significantly induced cell death (Figures 5f and h ) and decreased cell survival (Figures 5e and g ) in both cell lines even if cells have not been challenged by H 2 O 2 . This confirmed that MEK1 and 2 are major downstream signalling molecules of the IGF pathway and is involved with IGF-I protection for oxidative stress. In contrast to LY294002 and MEK1/2 inhibitors, the addition of SB203580 appears not to inhibit IGF-I protection cell from oxidative stress (Figures 5e-h ). Together all these data suggest that IGF-I protection of muscle cells from oxidative damage appears to proceed via the PI3K/Akt and ERK1/2 MAPK pathways, but not proceed via p38 MAPK pathway.
IGF-I Affect Pro-and Pre-Apoptotic Proteins Expression in Muscle Cells
To test whether pretreatment with IGF-I has any effect on apoptotic regulation proteins, the expression level of Bax (a pro-apoptotic protein) and Bcl2 (an anti-apoptotic protein) were examined by western blotting after muscle cells were incubated either with IGF-I alone, or with IGF-I plus PI3K inhibitor or with the p38 MAPK inhibitor. It was found that the ratio of Bcl2 to Bax in IGF-I-treated cells was significantly higher compared with untreated cells (Figures 7a  and b) indicating that pretreatment with IGF-I can reduce muscle cell apoptosis. When cells were pretreated with IGF-I and PI3K inhibitor (LY294002) the effect of IGF-I on the ratio of Bcl2 to Bax was neutralized (Figures 7a and b) confirming that IGF-I prevents cell from apoptosis via the PI3K/Akt pathway. If cells were pretreated with IGF-I plus a p38 MAPK inhibitor (SB203580), the effect of IGF-I on the ratio of Bcl2 to Bax was not significantly influenced compared with LY294002 suggesting that the p38 MAPK pathway seems not involved in the protective effect executed by IGF-I. 2 C 12 (a) and L 6 E 9 (b) skeletal muscle cells were pretreated with different concentrations (0, 50, and 100 ng/ml) of IGF-I for 24 h and then challenged by H 2 O 2 at concentrations of (0, 0.25, 0.5, and 1 mM) for 2 h. Dead cell was assessed with YOPRO-iodide (Invitrogen); cell death/survival ratio was calculated according to the method mentioned in the text. All data were represented as mean±s.e.m. of six samples (n ¼ 6). Po0.05 was considered as significant and indicated as *Po0.01 as higher significance and indicated as **P40.05 as not significant and marked as NS. c, d, g, h ) muscle cells were pretreated with IGF-I (100 ng/ml) alone, IGF-I (100 ng/ml) plus LY294002 (20 mM), IGF-I (100 ng/ml) plus SB203580 (20 mM), IGF-I (100 ng/ml) plus MEK1/2 (20 mM) for 24 h and challenged by H 2 O 2 (1 mM) for 2 h. Cell viability was determined with CellTiter-Blue reagent (Promega), cell survival (%) (a, c, e, g) was expressed as percentage of viable cell in treated groups to the untreated control group. Dead cell was assessed with YOPRO-iodide (Invitrogen); cell death/survival ratio (b, d, f, h) was calculated according to the method mentioned in the text. All data were represented as mean ± s.e.m. of six samples (n ¼ 6). Po0.05 was considered as significant and indicated as *Po0.01 as higher significance and indicated as **P40.05 as not significant and marked as NS.
DISCUSSION
Oxidative stress has a major role in the pathogenesis of many muscle diseases. The main contributors to oxidative stress in muscle tissue are ROS such as oxygen ions, free radicals, and peroxides. We used exogenous H 2 O 2 to induce two types of muscle cell oxidative stress and found that exogenous H 2 O 2 decreased muscle cell viability with an increase in caspaseindependent apoptosis. IGF-I is able to prevent muscle cells from H 2 O 2 -induced cell death and recovers cell viability. After further investigation, it was found that it is likely IGF-I executes its cell protection via the PI3K/Akt and ERK1/2 MAPK, but not p38 MAPK pathways.
It has been known that caspases have a central role in most apoptotic cell death, however, in addition to the classic caspase-mediated apoptosis, mammalian cells can also undergo caspase-independent apoptosis, 16 that is mediated by the dissipation of the inner Mt membrane potential and the release of apoptosis factors. The caspase-independent apoptosis has been documented in various death models including exposure to some agents that affect protein redox status. 17 Oxidation of redox-sensing inner membrane proteins was found to cause caspase-independent apoptosis in hybridoma T cells. 18 Although H 2 O 2 has been found to cause muscle myotube apoptosis, 7 it is not clear that H 2 O 2 -induced muscle cell death is what type of apoptosis. As far as we know this is the first report that H 2 O 2 induce muscle cell death is a type of caspase-independent apoptosis. It is interesting to note that two types of muscle cells used in the experiment have different sensitivity against H 2 O 2 challenge and L 6 E 9 cells are more susceptible to H 2 O 2 than C 2 C 12 cells. The reason for diverse responses to oxidative challenge in the two cell lines are not yet known. It is known that the level of IGF-I expression is very low or nonexistent in L 6 E 9 cells but the IGF-I receptor is present, while in C 2 C 12 cells both IGF-I and its receptor are highly expressed. 19 The fact that L 6 E 9 cells produce a very low level (if any) of IGF-I could be a reason why L 6 E 9 cells are more vulnerable to H 2 O 2 -induced oxidative stress than C 2 C 12 cells.
IGF-I is a single-chain peptide growth factor produced primarily by the liver and executes its action mainly through its receptor-insulin-like growth factor I receptor (IGF-IR). It can act as a systemic endocrine hormone or in a paracrine/ autocrine manner in target tissues. A recent in vivo study has found that IGF-IR is a mediator of cardiac hypertrophy, which involved oxidative stress in cardiac muscle. 20 In skeletal muscle IGF-I can increase muscle mass, promote muscle cell proliferation, differentiation, and survival. 21 Systemic administration of IGF-I or its analog has been shown to improve muscle function and reduce muscle susceptibility to contraction-mediated damage in dystrophic mdx mice. 22, 23 The mechanism by which IGF-I and its analog confer protection from contraction-mediated damage in dystrophic skeletal muscle is not clear. 23 It was found that prolonged IGF-I treatment in mdx mice can induce muscle fibers from a fast-twitch phenotype toward the slow-twitch phenotype without a change in fiber cross areas. 22 Compared with fasttwitch muscle, slow-twitch muscle fibers are rich in mitochondria, 24 have higher oxidative capacities, 25 and therefore use ATP in a more efficient way and produce less ROS, which would cause less or no damage to muscle cells. Our finding that IGF-I is able to prevent muscle cell from H 2 O 2 -induced cell death and recover cell viability may offer a rational explanation for IGF-I conferring protection on dystrophic muscle from contraction-induced damage. It is also interesting to note that this protective effect exists only when cells are pretreated by IGF-I for at least 24 h; if cells are treated with IGF-I and H 2 O 2 simultaneously, there is no protection (unpublished data). This indicates that IGF-I executes its protection action through an indirect way.
The effects of IGF-I are mediated mainly through IGF-IR, which has tyrosine kinase activity and signals through the PI3K/Akt pathway and MAPK pathway. There have been a number of studies highlighting the contradictory roles of the PI3K/Akt pathway in cell survival and apoptosis. For instance, it has been previously found that the PI3K/Akt pathway is involved in cell survival and the prevention of apoptosis 26 while another study reported that PI3K/Akt pathway activation by IGF-I is not required for cell survival, 27 and not involved in the IGF-I anti-apoptotic function against IFN/TNF-induced apoptosis. 28, 29 These contradictory findings raise the possibility of conflicting roles of PI3K/Akt under different conditions. To make sure the PI3K/Akt pathway is activated by IGF-I in muscle cells under the same conditions used in the experiment, both cell lines were treated with IGF-I alone or IGF-I plus LY294002 for 24 h, the level of total Akt and phosphor-Akt was determined by western blotting. It was found that PI3K/Akt pathway was activated by IGF-I in muscle cells under the same conditions used in all experiments and LY294002 can inhibit PI3K activation under the same conditions. Further examination of cell viability and cell death after incubation with LY294002 revealed that IGF-I protects muscle cells from oxidative damage through the activation of PI3K/Akt pathway. Similarly, MAPK pathway is another major signal transduction cascade responding to the IGF-I stimulation. Using MEK1/2 inhibitor and SB203580 to block MAPK pathways, we confirmed MEK1 and 2 are major downstream signalling molecules of IGF pathway and involved with IGF-I protection for oxidative stress. P38 MAPK seems not to be involved in the muscle cell protection shown by IGF-I. It is interesting to note a different response between cell survival and cell death in IGF-I and p38 MAPK inhibitor (SB203580) treatment groups (Figures 5e and f) . The difference may be due to the role that p38 has in the myoblast cell cycle. A previous report 30 has
shown that p38 has a critical role in the myoblast cell cycle. As p38 MAPK pathway is more implicated with the cell cycle, when it was inhibited, cell may stop proliferation and stay in the arrest state but not undergo apoptosis. As a result, the cell proliferation/survival will be severely disturbed, but cell death would not be affected. It has been reported that caspase-independent apoptosis results from the protein damage caused by the unbalance of redox status 16 and is linked with Mt membrane permeability. 31 A recent study using IGF-I to treat old rats has found that IGF-I treatment has led to a reduction of free radical production in the liver and that this action is through a Mt protection. 32 Bax and Bcl-2 are two main proteins to mediate Mt membrane permeability. 33 Bax is a pro-apoptotic protein, which forms a trans-membrane pore across the outer Mt membrane, leading to loss of membrane potential and enhances apoptosis. Bcl-2 is an anti-apoptotic protein, which prevents the pore formation and cell death. The ratio of Bcl2 to Bax can be a marker to indicate the level of apoptosis. 33 Our study shows that IGF-I reduces the muscle cell apoptotic level significantly and the PI3K inhibitor neutralise IGF-I action on apoptosis but p38 MAPK inhibitor has not affected apoptotic level. All these data suggest that IGF-I prevents cell from apoptosis through the PI3K/Akt and ERK1/2 MAPK pathways, but not via the p38 MAPK pathway.
Recombinant IGF-I has been produced on a large scale and has been in clinical trials for a variety of pathological conditions including growth failure, 34 type I 35 and type II diabetes. 36 Although there are many studies using IGF-I as a therapeutic agent to treat dystrophic muscle wasting in an animal model, the mechanism by which IGF-I protects cells from oxidative stress is still not clear. This study has offered a rational mechanism by which IGF-I prevents muscle from contract-mediated damage in a dystrophic animal model. In summary, exogenous H 2 O 2 can induce oxidative damage in skeletal muscle cells and cause muscle cell caspaseindependent apoptotic death. Pretreatment by IGF-I can protect muscle cells from oxidative stress by increasing the ratio of the anti-apoptotic protein (Bcl 2) to the pro-apoptotic protein (Bax). The protection of IGF-1 seems to be via the PI3K/Akt and ERK1/2 MAPK pathways. Protecting muscle cells from oxidative damage presents a potential application in the treatment of muscle wasting, which occurs in many pathological muscle conditions including DMD and sarcopenia.
